📰 Aipsc News
Page 4 - Aipsc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aipsc. Real-time updates on events, politics, business and more.
June 13, 2022
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) have been given an average rating of “Buy” by the seven ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price […]
June 10, 2022
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 259 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors? We will compare Century Therapeutics to similar companies based on the strength of its risk, institutional ownership, analyst recommendations, earnings, dividends, profitability and valuation. Profitability This […]
June 10, 2022
Equities researchers at Roth Capital began coverage on shares of Century Therapeutics (NASDAQ:IPSC – Get Rating) in a research note issued on Friday, The Fly reports. The brokerage set a “buy” rating on the stock. Several other equities research analysts have also recently commented on IPSC. HC Wainwright began coverage on Century Therapeutics in a […]
June 7, 2022
The AIPSC was inaugurated by K K Shailaja, former Health Minister, Kerala. Other speakers included Dr Sabyasachi Chatterjee, President AIPSN, Indumathi D and Rajesh Joshi, writer and poet.
June 6, 2022
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 259 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Century Therapeutics to related companies based on the strength of its risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Insider and […]
May 30, 2022
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 259 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Century Therapeutics to similar companies based on the strength of its institutional ownership, earnings, analyst recommendations, valuation, risk, dividends and profitability. Institutional & […]
May 29, 2022
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 255 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Century Therapeutics to similar companies based on the strength of its profitability, earnings, valuation, dividends, institutional ownership, risk and analyst recommendations. Earnings and […]
May 20, 2022
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) has received an average rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokerages […]
April 22, 2022
He made the above remark during addressing the gathering at the inauguration of the 48th All India Police Science Congress (AIPSC) meet here.
April 15, 2022
Union HM Amit Shah to head to MP, Bihar, Puducherry for three-visit tour from April 22 to 24 - On April 22, the Home Minister will be participating in 48th All India Police Science Congress (AIPSC) meeting in Bhopal as the chief guest at 11 am